Vertex has enacted or continued several key launches in 2025. These include its new once-daily triple-combination therapy for ...
Explore how oligonucleotides are reshaping therapeutics, diagnostics and CRISPR with rapid, scalable and personalized ...
The COVID-19 vaccines manufactured by Pfizer-BioNTech and Moderna ... mRNA is also being used in tandem with the gene-editing ...
As flu season approaches and public health officials roll out their annual push for vaccination, Allen Institute scientists ...
News-Medical.Net on MSN
Understanding age-related changes in T cells and vaccine response
As flu season approaches and public health officials roll out their annual push for vaccination, Allen Institute scientists ...
Q3 2025 Earnings Call October 28, 2025 8:30 AM EDTCompany ParticipantsJacob JohnsonOlivier Loeillot - President, ...
Recursion, Roche, and its Genentech subsidiary have unveiled a whole-genome map of specialized microglial immune cells that they plan to use toward revealing significant new targets in ...
GeneVentiv Therapeutics, Inc., a privately held biotechnology company developing one-time gene therapies for rare and inherited diseases, today announced that it held a successful INTERACT meeting ...
As flu season returns and vaccines are rolled out, researchers at the Allen Institute are uncovering why vaccines don’t work ...
President Donald Trump has received updated flu and COVID-19 booster shots in preparation for upcoming travel, the president’s physician announced Oct. 10. Sean P. Barbabella, a U.S. Navy captain, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback